Items where Division is "03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Neurologie > Neuroimmunologie (Kappos)
|
 | Up a level |
UNSPECIFIED. (2015) Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. Journal of neuroinflammation, Vol. 12. p. 46.
Mayer, Marie C. and Breithaupt, Constanze and Reindl, Markus and Schanda, Kathrin and Rostásy, Kevin and Berger, Thomas and Dale, Russell C. and Brilot, Fabienne and Olsson, Tomas and Jenne, Dieter and Pröbstel, Anne-Katrin and Dornmair, Klaus and Wekerle, Hartmut and Hohlfeld, Reinhard and Banwell, Brenda and Bar-Or, Amit and Meinl, Edgar. (2013) Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases. Journal of immunology (Baltimore, Md. : 1950), 191 (7). pp. 3594-3604.
Sutter, Raoul and Mengiardi, Bernard and Benz, Daniela and Heijnen, Ingmar and Kappos, Ludwig and Winkler, David T.. (2012) Facial nerve palsy and anti-Ku autoantibodies. Journal of neurology, Vol. 259, H. 2. pp. 361-363.
Kuhle, Jens and Gosert, Rainer and Buhler, R. and Derfuss, Tobias and Sutter, R and Yaldizli, Ozgür and Radue, E. W. and Ryschkewitsch, C. and Major, E. O. and Kappos, Ludwig and Frank, Stephan and Hirsch, Hans H.. (2011) Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS. Neurology, 77 (23). pp. 2010-2016.
Acaster, S. and Swinburn, P. and Wang, C. and Stemper, B. and Beckmann, K. and Knappertz, V. and Pohl, C. and Sandbrink, R. and Gondek, K. and Edan, G. and Kappos, L. and Freedman, M. and Hartung, H.-P. and Arnason, B. and Comi, G. and Filippi, M. and Jeffery, D. and O'Connor, P. and Cook, S. and Lloyd, A. J.. (2011) Can the functional assessment of multiple sclerosis adapt to changing needs? : a psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 17 (12). pp. 1504-1513.
Bush, W. S. and McCauley, J. L. and DeJager, P. L. and Dudek, S. M. and Hafler, D. A. and Gibson, R. A. and Matthews, P. M. and Kappos, L. and Naegelin, Y. and Polman, C. H. and Hauser, S. L. and Oksenberg, J. and Haines, J. L. and Ritchie, M. D. and International Multiple Sclerosis Genetics Consortium, . (2011) A knowledge-driven interaction analysis reveals potential neurodegenerative mechanism of multiple sclerosis susceptibility. Genes and immunity, Vol. 12, H. 5. pp. 335-340.
Filippi, M. and Rocca, M. A. and Camesasca, F. and Cook, S. and O'Connor, P. and Arnason, B. G. W. and Kappos, L. and Goodin, D. and Jeffery, D. and Hartung, H.-P. and Comi, G. and Wolinsky, J. S. and Bogumil, T. and Pohl, C. and Beckmann, K. and Sandbrink, R. and Croze, E. and Brown, C. and Desimone, T. M. and Arnold, D. L. and Cutter, G. and Knappertz, V.. (2011) Interferon β-1b and glatiramer acetate effects on permanent black hole evolution. Neurology, Vol. 76, H. 14. pp. 1222-1228.
Hartung, H.-P. and Freedman, M. S. and Polman, C. H. and Edan, G. and Kappos, L. and Miller, D. H. and Montalbán, X. and Barkhof, F. and Petkau, J. and White, R. and Sahajpal, V. and Knappertz, V. and Beckmann, K. and Lanius, V. and Sandbrink, R. and Pohl, C. and Benefit Study Group, . (2011) Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome. Neurology, Vol. 77, H. 9. pp. 835-843.
Kappos, Ludwig and Li, David and Calabresi, Peter A. and O'Connor, Paul and Bar-Or, Amit and Barkhof, Frederik and Yin, Ming and Leppert, David and Glanzman, Robert and Tinbergen, Jeroen and Hauser, Stephen L.. (2011) Ocrelizumab in relapsing-remitting multiple sclerosis : a phase 2, randomised, placebo-controlled, multicentre trial. Lancet, Vol. 378, no. 9805. pp. 1779-1787.
Katan, M. and Nigro, N. and Fluri, F. and Schuetz, P. and Morgenthaler, N. G. and Jax, F. and Meckel, S. and Gass, A. and Bingisser, R. and Steck, A. and Kappos, L. and Engelter, S. and Müller, B. and Christ-Crain, M.. (2011) Stress hormones predict cerebrovascular re-events after transient ischemic attacks. Neurology, Vol. 76, H. 6. pp. 563-566.
Khatri, Bhupendra and Barkhof, Frederik and Comi, Giancarlo and Hartung, Hans-Peter and Kappos, Ludwig and Montalban, Xavier and Pelletier, Jean and Stites, Tracy and Wu, Stacy and Holdbrook, Fred and Zhang-Auberson, Lixin and Francis, Gordon and Cohen, Jeffrey A. and Transforms Study Group, . (2011) Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis : a randomised extension of the TRANSFORMS study. The Lancet neurology, Vol. 10, H. 6. pp. 520-529.
Kuhle, J. and Leppert, D. and Petzold, A. and Regeniter, A. and Schindler, C. and Mehling, M. and Anthony, D. C. and Kappos, L. and Lindberg, R. L.. (2011) Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis. Neurology, Vol. 76, H. 14. pp. 1206-1213.
MacManus, D. G. and Miller, D. H. and Kappos, L. and Gold, R. and Havrdova, E. and Limmroth, V. and Polman, C. H. and Schmierer, K. and Yousry, T. A. and Eraksoy, M. and Meluzinova, E. and Dufek, M. and Yang, M. and O'Neill, G. N. and Dawson, K.. (2011) BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis. Journal of neurology, Vol. 258, H. 3. pp. 449-456.
Mehling, M. and Hilbert, P. and Fritz, S. and Durovic, B. and Eichin, D. and Gasser, O. and Kuhle, J. and Klimkait, T. and Lindberg, R. L. P. and Kappos, L. and Hess, C.. (2011) Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patients. Annals of neurology, Vol. 69, H. 2. pp. 408-413.
Mehling, M. and Johnson, T. A. and Antel, J. and Kappos, L. and Bar-Or, A.. (2011) Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis. Neurology, Vol. 76, H. 8, Suppl. 3 , S20-S27.
Mehling, Matthias and Kappos, Ludwig and Derfuss, Tobias. (2011) Fingolimod for multiple sclerosis : mechanism of action, clinical outcomes, and future directions. Current neurology and neuroscience reports, Vol. 11, no. 5. pp. 492-797.
Meinl, Edgar and Derfuss, Tobias and Krumbholz, Markus and Pröbstel, Anne-Katrin and Hohlfeld, Reinhard. (2011) Humoral autoimmunity in multiple sclerosis. Journal of the neurological sciences, Vol. 306, No. 1/2. pp. 180-182.
Montalban, X. and Comi, G. and O'Connor, P. and Gold, Sm and de Vera, A. and Eckert, B. and Kappos, L.. (2011) Oral fingolimod (FTY720) in relapsing multiple sclerosis : impact on health-related quality of life in a phase II study. Multiple Sclerosis Journal, 17 (11). pp. 1341-1350.
Neidert, S. and Katan, M. and Schuetz, P. and Fluri, F. and Ernst, A. and Bingisser, R. and Kappos, L. and Engelter, S. T. and Steck, A. and Müller, B. and Christ-Crain, M.. (2011) Anterior pituitary axis hormones and outcome in acute ischaemic stroke. Journal of Internal Medicine, 269 (4). pp. 420-432.
O'Connor, P. W. and Goodman, A. and Kappos, L. and Lublin, F. D. and Miller, D. H. and Polman, C. and Rudick, R. A. and Aschenbach, W. and Lucas, N.. (2011) Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis. Neurology, Vol. 76, H. 22. pp. 1858-1865.
O'Connor, Paul and Wolinsky, Jerry S. and Confavreux, Christian and Comi, Giancarlo and Kappos, Ludwig and Olsson, Tomas P. and Benzerdjeb, Hadj and Truffinet, Philippe and Wang, Lin and Miller, Aaron and Freedman, Mark S. and Temso Trial Group, . (2011) Randomized trial of oral teriflunomide for relapsing multiple sclerosis. The New England journal of medicine, Vol. 365, H. 14. pp. 1293-1303.
Osthoff, M. and Katan, M. and Fluri, F. and Schuetz, P. and Bingisser, R. and Kappos, L. and Steck, A. J. and Engelter, S. T. and Mueller, B. and Christ-Crain, M. and Trendelenburg, M.. (2011) Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients. PLoS One, Vol. 6, H. 6 , e21338.
Patsopoulos, Nikolaos A. and Bayer Pharma MS Genetics Working Group, and ANZgene Consortium, and GeneMSA, and International Multiple Sclerosis Genetics Consortium, and de Bakker, Paul I. W. and Esposito, Federica and Reischl, Joachim and Lehr, Stephan and Bauer, David and Heubach, Jürgen and Sandbrink, Rupert and Pohl, Christoph and Edan, Gilles and Kappos, Ludwig and Miller, David and Montalbán, Javier and Polman, Chris H. and Freedman, Mark S. and Hartung, Hans-Peter and Arnason, Barry G. W. and Comi, Giancarlo and Cook, Stuart and Filippi, Massimo and Goodin, Douglas S. and Jeffery, Douglas and O'Connor, Paul and Ebers, George C. and Langdon, Dawn and Reder, Anthony T. and Traboulsee, Anthony and Zipp, Frauke and Schimrigk, Sebastian and Hillert, Jan and Bahlo, Melanie and Booth, David R. and Broadley, Simon and Brown, Matthew A. and Browning, Brian L. and Browning, Sharon R. and Butzkueven, Helmut and Carroll, William M. and Chapman, Caron and Foote, Simon J. and Griffiths, Lyn and Kermode, Allan G. and Kilpatrick, Trevor J. and Lechner-Scott, Jeanette and Marriott, Mark and Mason, Deborah and Moscato, Pablo and Heard, Robert N. and Pender, Michael P. and Perreau, Victoria M. and Perera, Devindri and Rubio, Justin P. and Scott, Rodney J. and Slee, Mark and Stankovich, Jim and Stewart, Graeme J. and Taylor, Bruce V. and Tubridy, Niall and Willoughby, Ernest and Wiley, James and Matthews, Paul and Boneschi, Filippo M. and Compston, Alastair and Haines, Jonathan and Hauser, Stephen L. and McCauley, Jacob and Ivinson, Adrian and Oksenberg, Jorge R. and Pericak-Vance, Margaret and Sawcer, Stephen J. and De Jager, Philip L. and Hafler, David A.. (2011) Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Annals of Neurology, 70 (6). pp. 897-912.
Polman, Chris H. and Reingold, Stephen C. and Banwell, Brenda and Clanet, Michel and Cohen, Jeffrey A. and Filippi, Massimo and Fujihara, Kazuo and Havrdova, Eva and Hutchinson, Michael and Kappos, Ludwig and Lublin, Fred D. and Montalban, Xavier and O'Connor, Paul and Sandberg-Wollheim, Magnhild and Thompson, Alan J. and Waubant, Emmanuelle and Weinshenker, Brian and Wolinsky, Jerry S.. (2011) Diagnostic criteria for multiple sclerosis : 2010 revisions to the McDonald criteria. Annals of neurology, Vol. 69, H. 2. pp. 292-302.
Probstel, A. K. and Dornmair, K. and Bittner, R. and Sperl, P. and Jenne, D. and Magalhaes, S. and Villalobos, A. and Breithaupt, C. and Weissert, R. and Jacob, U. and Krumbholz, M. and Kuempfel, T. and Blaschek, A. and Stark, W. and Gartner, J. and Pohl, D. and Rostasy, K. and Weber, F. and Forne, I. and Khademi, M. and Olsson, T. and Brilot, F. and Tantsis, E. and Dale, R. C. and Wekerle, H. and Hohlfeld, R. and Banwell, B. and Bar-Or, A. and Meinl, E. and Derfuss, T.. (2011) Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology, 77 (6). pp. 580-588.
Roosendaal, Stefan D. and Bendfeldt, Kerstin and Vrenken, Hugo and Polman, Chris H. and Borgwardt, Stefan and Radue, Ernst W. and Kappos, Ludwig and Pelletier, Daniel and Hauser, Stephen L. and Matthews, Paul M. and Barkhof, Frederik and Geurts, Jeroen J. G.. (2011) Grey matter volume in a large cohort of MS patients : relation to MRI parameters and disability. Multiple Sclerosis Journal, 17 (9). pp. 1098-1106.
Rudick, R. A. and Kappos, L. and Kinkel, R. and Clanet, M. and Phillips, J. T. and Herndon, R. M. and Sandrock, A. W. and Munschauer, F. E.. (2011) Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis : analysis of 1406 patients. Multiple Sclerosis Journal, 17 (3). pp. 353-360.
Schlede, Nina and Zimmermann, Ronan and Ehrensperger, Michael M. and Gschwandtner, Ute and Hardmeier, Martin and Hatz, Florian and Monsch, Andreas U. and Naegelin, Yvonne and Fuhr, Peter. (2011) Clinical EEG in cognitively impaired patients with Parkinson's Disease. Journal of the neurological sciences, Vol. 310, No. 1-2. pp. 75-78.
Sombekke, M. H. and Jafari, N. and Bendfeldt, K. and Mueller-Lenke, N. and Radue, E. W. and Naegelin, Y. and Kappos, L. and Matthews, P. M. and Polman, C. H. and Barkhof, F. and Hintzen, R. and Geurts, J. J. G.. (2011) No influence of KIF1B on neurodegenerative markers in multiple sclerosis. Neurology, Vol. 76, H. 21. pp. 1843-1845.
Uitdehaag, Bernard and Constantinescu, Cris and Cornelisse, Peter and Jeffery, Douglas and Kappos, Ludwig and Li, David and Sandberg-Wollheim, Magnhild and Traboulsee, Anthony and Verdun, Elisabetta and Rivera, Victor. (2011) Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis : exploratory analyses from the PRISMS long-term follow-up study. Therapeutic Advances in Neurological Disorders, 4 (1). pp. 3-14.
Vermersch, P. and Kappos, L. and Gold, R. and Foley, J. F. and Olsson, T. and Cadavid, D. and Bozic, C. and Richman, S.. (2011) Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy. Neurology, Vol. 76, H. 20. pp. 1697-1704.
Waschbisch, A. and Sandbrink, R. and Hartung, H.-P. and Kappos, L. and Schwab, S. and Pohl, C. and Wiendl, H.. (2011) Evaluation of soluble HLA-G as a biomarker for multiple sclerosis. Neurology, Vol. 77, H. 6. pp. 596-598.
Bendfeldt, K. and Kappos, L. and Radue, E. W. and Borgwardt, S.. (2010) Longitudinal spatiotemporal distribution of gray and white matter pathology in multiple sclerosis. American journal of neuroradiology, Vol. 31, H. 5 , E45.
Bendfeldt, Kerstin and Egger, Hanspeter and Nichols, Thomas E. and Loetscher, Patrick and Denier, Niklaus and Kuster, Pascal and Traud, Stefan and Mueller-Lenke, Nicole and Naegelin, Yvonne and Gass, Achim and Kappos, Ludwig and Radue, Ernst-Wilhelm and Borgwardt, Stefan J.. (2010) Effect of immunomodulatory medication on regional gray matter loss in relapsing-remitting multiple sclerosis : a longitudinal MRI study. Brain research, Vol. 1325. pp. 174-182.
Cantoni, Nathan and Meyer, Peter and Katan, Mira and Kappos, Ludwig and Hess, Christoph and Daikeler, Thomas. (2010) A confusing patient's history : small or large vessel vasculitis? Rheumatology international, Vol. 30, H. 12. pp. 1681-1683.
Cohen, Jeffrey A. and Barkhof, Frederik and Comi, Giancarlo and Hartung, Hans-Peter and Khatri Bhupendra, O. and Montalban, Xavier and Pelletier, Jean and Capra, Ruggero and Gallo, Paolo and Izquierdo, Guillermo and Tiel-Wilck, Klaus and de Vera, Ana and Jin, James and Stites, Tracy and Wu, Stacy and Aradhye, Shreeram and Kappos, Ludwig and Transforms Study Group, . (2010) Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. The New England journal of medicine, Vol. 362, H. 5. pp. 402-415.
Comi, G. and O'Connor, P. and Montalban, X. and Antel, J. and Radue, E.-W. and Karlsson, G. and Pohlmann, H. and Aradhye, S. and Kappos, L.. (2010) Phase II study of oral fingolimod (FTY720) in multiple sclerosis : 3-year results. Multiple Sclerosis Journal, 16 (2). pp. 197-207.
Gilli, Francesca and Lindberg, Raija L. P. and Valentino, Paola and Marnetto, Fabiana and Malucchi, Simona and Sala, Arianna and Capobianco, Marco and di Sapio, Alessia and Sperli, Francesca and Kappos, Ludwig and Calogero, Raffaele A. and Bertolotto, Antonio. (2010) Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis. PLoS one, Vol. 5 , e8962.
Grossman, P. and Kappos, L. and Gensicke, H. and D'Souza, M. and Mohr, D. C. and Penner, I. K. and Steiner, C.. (2010) MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial. Neurology : journal of the American Academy of Neurology, Vol. 75, H. 13. pp. 1141-1149.
Jakkula, Eveliina and Leppä, Virpi and Sulonen, Anna-Maija and Varilo, Teppo and Kallio, Suvi and Kemppinen, Anu and Purcell, Shaun and Koivisto, Keijo and Tienari, Pentti and Sumelahti, Marja-Liisa and Elovaara, Irina and Pirttilä, Tuula and Reunanen, Mauri and Aromaa, Arpo and Oturai, Annette Bang and Søndergaard, Helle Bach and Harbo, Hanne F. and Mero, Inger-Lise and Gabriel, Stacey B. and Mirel, Daniel B. and Hauser, Stephen L. and Kappos, Ludwig and Polman, Chris and De Jager, Philip L. and Hafler, David A. and Daly, Mark J. and Palotie, Aarno and Saarela, Janna and Peltonen, Leena. (2010) Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. American journal of human genetics, Vol. 86, H. 2. pp. 285-291.
Kappos, Ludwig and Mehling, Matthias. (2010) Images in clinical medicine : dissociation of voluntary and emotional innervation after stroke. The New England journal of medicine, Vol. 363, H. 16 , e25.
Kappos, Ludwig and Radue, Ernst-Wilhelm and O'Connor, Paul and Polman, Chris and Hohlfeld, Reinhard and Calabresi, Peter and Selmaj, Krzysztof and Agoropoulou, Catherine and Leyk, Malgorzata and Zhang-Auberson, Lixin and Burtin, Pascale and Freedoms Study Group, . (2010) A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. The New England journal of medicine, Vol. 362, H. 5. pp. 387-401.
Katan, Mira and Fluri, Felix and Schuetz, Philipp and Morgenthaler, Nils G. and Zweifel, Christian and Bingisser, Roland and Kappos, Ludwig and Steck, Andreas and Engelter, Stefan T. and Müller, Beat and Christ-Crain, Mirjam. (2010) Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke. Journal of the American College of Cardiology, 56 (13). pp. 1045-1053.
Kuhle, Jens and Regeniter, Axel and Leppert, David and Mehling, Matthias and Kappos, Ludwig and Lindberg, Raija L. P. and Petzold, Axel. (2010) A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein. Journal of neuroimmunology, Vol. 220, H. 1/2. pp. 114-119.
Lindberg, Raija L. P. and Hoffmann, Francine and Mehling, Matthias and Kuhle, Jens and Kappos, Ludwig. (2010) Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients. European journal of immunology, Vol. 40, H. 3. pp. 888-898.
Lövblad, K.-O. and Anzalone, N. and Dörfler, A. and Essig, M. and Hurwitz, B. and Kappos, L. and Lee, S.-K. and Filippi, M.. (2010) MR imaging in multiple sclerosis : review and recommendations for current practice. American journal of neuroradiology, Vol. 31, H. 6. pp. 983-989.
Mehling, M. and Lindberg, R. and Raulf, F. and Kuhle, J. and Hess, C. and Kappos, L. and Brinkmann, V.. (2010) Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis. Neurology, Vol. 75, H. 5. pp. 403-410.
Mesaros, S. and Rocca, Ma and Sormani, Mp and Valsasina, P. and Markowitz, C. and De Stefano, N. and Montalban, X. and Barkhof, F. and Ranjeva, Jp and Sailer, M. and Kappos, L. and Comi, G. and Filippi, M.. (2010) Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis : a 14-month, multicentre, follow-up study. Multiple Sclerosis Journal, 16 (3). pp. 325-331.
Montalban, X. and Tintoré, M. and Swanton, J. and Barkhof, F. and Fazekas, F. and Filippi, M. and Frederiksen, J. and Kappos, L. and Palace, J. and Polman, C. and Rovaris, M. and de Stefano, N. and Thompson, A. and Yousry, T. and Rovira, A. and Miller, D. H.. (2010) MRI criteria for MS in patients with clinically isolated syndromes. Neurology, Vol. 74, H. 5. pp. 427-434.
Morrow, S. A. and O'Connor, P. W. and Polman, C. H. and Goodman, A. D. and Kappos, L. and Lublin, F. D. and Rudick, R. A. and Jurgensen, S. and Paes, D. and Forrestal, F. and Benedict, R. H. B.. (2010) Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks. Multiple Sclerosis Journal, 16 (11). pp. 1385-1392.
Papadopoulou, Athina and D'Souza, Marcus and Kappos, Ludwig and Yaldizli, Ozgür. (2010) Dimethyl fumarate for multiple sclerosis. Expert opinion on investigational drugs, Vol. 19, no. 12. pp. 1603-1612.
Petzold, Axel and Mondria, Tjeerd and Kuhle, Jens and Rocca, Maria A. and Cornelissen, Jan and te Boekhorst, Peter and Lowenberg, Bob and Giovannoni, Gavin and Filippi, Massimo and Kappos, Ludwig and Hintzen, Rogier. (2010) Evidence for acute neurotoxicity after chemotherapy. Annals of neurology, Vol. 68, H. 6. pp. 806-815.
Rudick, Richard A. and Kappos, Ludwig. (2010) Measuring disability in relapsing-remitting MS. Neurology, Vol. 75, H. 4. pp. 296-297.
Sahraian, M. A. and Radue, E.-W. and Haller, S. and Kappos, L.. (2010) Black holes in multiple sclerosis : definition, evolution, and clinical correlations. Acta neurologica scandinavica, Vol. 122, H. 1. pp. 1-8.
Urwyler, Sandrine A. and Schuetz, Philipp and Fluri, Felix and Morgenthaler, Nils G. and Zweifel, Christian and Bergmann, Andreas and Bingisser, Roland and Kappos, Ludwig and Steck, Andreas and Engelter, Stefan and Müller, Beat and Christ-Crain, Mirjam and Katan, Mira. (2010) Prognostic value of copeptin: one-year outcome in patients with acute stroke. Stroke, 41 (7). pp. 1564-1567.
van den Elskamp, I. J. and Boden, B. and Dattola, V. and Knol, D. L. and Filippi, M. and Kappos, L. and Fazekas, F. and Wagner, K. and Pohl, C. and Sandbrink, R. and Polman, C. H. and Uitdehaag, B. M. J. and Barkhof, F.. (2010) Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis. Neuroradiology, Vol. 52, H. 10. pp. 875-881.
van den Elskamp, I. J. and Knol, D. L. and Vrenken, H. and Karas, G. and Meijerman, A. and Filippi, M. and Kappos, L. and Fazekas, F. and Wagner, K. and Pohl, C. and Sandbrink, R. and Polman, C. H. and Uitdehaag, B. M. J. and Barkhof, F.. (2010) Lesional magnetization transfer ratio : a feasible outcome for remyelinating treatment trials in multiple sclerosis. Multiple Sclerosis Journal, 16 (6). pp. 660-669.
Altmann, D. R. and Jasperse, B. and Barkhof, F. and Beckmann, K. and Filippi, M. and Kappos, L. D. and Molyneux, P. and Polman, C. H. and Pozzilli, C. and Thompson, A. J. and Wagner, K. and Yousry, T. A. and Miller, D. H.. (2009) Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis. Neurology : journal of the American Academy of Neurology, Vol. 72. pp. 595-601.
Baranzini, S. E. and Wang, J. and Gibson, R. A. and Galwey, N. and Naegelin, Y. and Barkhof, F. and Radue, E. W. and Lindberg, R. L. and Uitdehaag, B. M. and Johnson, M. R. and Angelakopoulou, A. and Hall, L. and Richardson, J. C. and Prinjha, R. K. and Gass, A. and Geurts, J. J. and Kragt, J. and Sombekke, M. and Vrenken, H. and Qualley, P. and Lincoln, R. R. and Gomez, R. and Caillier, S. J. and George, M. F. and Mousavi, H. and Guerrero, R. and Okuda, D. T. and Cree, B. A. and Green, A. J. and Waubant, E. and Goodin, D. S. and Pelletier, D. and Matthews, P. M. and Hauser, S. L. and Kappos, L. and Polman, C. H. and Oksenberg, J. R.. (2009) Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Human Molecular Genetics, Vol. 18. pp. 767-778.
Baranzini, Sergio E. and Galwey, Nicholas W. and Wang, Joanne and Khankhanian, Pouya and Lindberg, Raija and Pelletier, Daniel and Wu, Wen and Uitdehaag, Bernard M. J. and Kappos, Ludwig and Polman, Chris H. and Matthews, Paul M. and Hauser, Stephen L. and Gibson, Rachel A. and Oksenberg, Jorge R. and Barnes, Michael R.. (2009) Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Human Molecular Genetics, Vol. 18. pp. 2078-2090.
Bendfeldt, K. and Radue, E. W. and Borgwardt, S. J. and Kappos, L.. (2009) Progression of gray matter atrophy and its association with white matter lesions in relapsing-remitting multiple sclerosis. Journal of the neurological sciences, Vol. 285, No. 1-2 , S. 268-269 ; author reply 269.
Bendfeldt, Kerstin and Kuster, Pascal and Traud, Stefan and Egger, Hanspeter and Winklhofer, Sebastian and Mueller-Lenke, Nicole and Naegelin, Yvonne and Gass, Achim and Kappos, Ludwig and Matthews, Paul M. and Nichols, Thomas E. and Radue, Ernst-Wilhelm and Borgwardt, Stefan J.. (2009) Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis : alongitudinal voxel-based morphometry study. NeuroImage : a journal of brain function, Vol. 45. pp. 60-67.
De Jager, Philip L. and Jia, Xiaoming and Wang, Joanne and de Bakker, Paul I. W. and Ottoboni, Linda and Aggarwal, Neelum T. and Piccio, Laura and Raychaudhuri, Soumya and Tran, Dong and Aubin, Cristin and Briskin, Rebeccah and Romano, Susan and Baranzini, Sergio E. and McCauley, Jacob L. and Pericak-Vance, Margaret A. and Haines, Jonathan L. and Gibson, Rachel A. and Naeglin, Yvonne and Uitdehaag, Bernard and Matthews, Paul M. and Kappos, Ludwig and Polman, Chris and McArdle, Wendy L. and Strachan, David P. and Evans, Denis and Cross, Anne H. and Daly, Mark J. and Compston, Alastair and Sawcer, Stephen J. and Weiner, Howard L. and Hauser, Stephen L. and Hafler, David A. and Oksenberg, Jorge R.. (2009) Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nature genetics, Vol. 41. pp. 776-782.
Goebels, Norbert and Kappos, Ludwig. (2009) Another complication of natalizumab treatment? Taking the challenge. Annals of neurology, Vol. 66, H. 3. pp. 264-266.
Gugleta, K. and Kochkorov, A. and Kavroulaki, D. and Katamay, R. and Weier, K. and Mehling, M. and Kappos, L. and Flammer, J. and Orgül, S.. (2009) Retinal vessels in patients with multiple sclerosis : baseline diameter and response to flicker light stimulation. Klinische Monatsblätter für Augenheilkunde, Vol. 226, H. 4. pp. 272-275.
Hohlfeld, Reinhard and Kappos, Ludwig. (2009) Progress in understanding inflammatory and autoimmune diseases of the central nervous system. Seminars in immunopathology, Vol. 31. pp. 437-438.
Hutchinson, Michael and Kappos, Ludwig and Calabresi, Peter A. and Confavreux, Christian and Giovannoni, Gavin and Galetta, Steven L. and Havrdova, Eva and Lublin, Fred D. and Miller, David H. and O'Connor, Paul W. and Phillips, J. Theodore and Polman, Chris H. and Radue, Ernst-Wilhelm and Rudick, Richard A. and Stuart, William H. and Wajgt, Andrzej and Weinstock-Guttman, Bianca and Wynn, Daniel R. and Lynn, Frances and Panzara, Michael A.. (2009) The efficacy of natalizumab in patients with relapsing multiple sclerosis : subgroup analyses of AFFIRM and SENTINEL. Journal of neurology : official journal of the European Neurological Society ... [et al.] = Zeitschrift für Neurologie, Vol. 256. pp. 405-415.
Kappos, Ludwig and Freedman, Mark S. and Polman, Chris H. and Edan, Gilles and Hartung, Hans-Peter and Miller, David H. and Montalbán, Xavier and Barkhof, Frederik and Radü, Ernst-Wilhelm and Metzig, Carola and Bauer, Lars and Lanius, Vivian and Sandbrink, Rupert and Pohl, Christoph. (2009) Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis : 5-year active treatment extension of the phase 3 BENEFIT trial. The Lancet neurology, Vol. 8. pp. 987-997.
Katan, Mira and Fluri, Felix and Morgenthaler, Nils G. and Schuetz, Philipp and Zweifel, Christian and Bingisser, Roland and Müller, Klaus and Meckel, Stephan and Gass, Achim and Kappos, Ludwig and Steck, Andreas J. and Engelter, Stefan T. and Müller, Beat and Christ-Crain, Mirjam. (2009) Copeptin : a novel, independent prognostic marker in patients with ischemic stroke. Annals of neurology : official journal of the American Neurological Association and the Child Neurology Society, Vol. 66. pp. 799-808.
Kochkorov, A. and Gugleta, K. and Kavroulaki, D. and Katamay, R. and Weier, K. and Mehling, M. and Kappos, L. and Flammer, J. and Orgül, S.. (2009) Rigidity of retinal vessels in patients with multiple sclerosis. Klinische Monatsblätter für Augenheilkunde, Vol. 226, H. 4. pp. 276-279.
Kuhle, J. and Lindberg, R. L. P. and Regeniter, A. and Mehling, M. and Steck, A. J. and Kappos, L. and Czaplinski, A.. (2009) Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. European journal of neurology, Vol. 16. pp. 771-774.
Mancini, L. and Ciccarelli, O. and Manfredonia, F. and Thornton, J. S. and Agosta, F. and Barkhof, F. and Beckmann, C. and De Stefano, N. and Enzinger, C. and Fazekas, F. and Filippi, M. and Gass, A. and Hirsch, J. G. and Johansen-Berg, H. and Kappos, L. and Korteweg, T. and Manson, S. C. and Marino, S. and Matthews, P. M. and Montalban, X. and Palace, J. and Polman, C. and Rocca, M. and Ropele, S. and Rovira, A. and Wegner, C. and Friston, K. and Thompson, A. and Yousry, T.. (2009) Short-term adaptation to a simple motor task : a physiological process preserved in multiple sclerosis. NeuroImage : a journal of brain function, Vol. 45. pp. 500-511.
McLaughlin, Katherine A. and Chitnis, Tanuja and Newcombe, Jia and Franz, Bettina and Kennedy, Julia and McArdel, Shannon and Kuhle, Jens and Kappos, Ludwig and Rostasy, Kevin and Pohl, Daniela and Gagne, Donald and Ness, Jayne M. and Tenembaum, Silvia and O'Connor, Kevin C. and Viglietta, Vissia and Wong, Susan J. and Tavakoli, Norma P. and de Seze, Jerome and Idrissova, Zhannat and Khoury, Samia J. and Bar-Or, Amit and Hafler, David A. and Banwell, Brenda and Wucherpfennig, Kai W.. (2009) Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. Journal of immunology : official journal of the American Association of Immunologists, Vol. 183. pp. 4067-4076.
Mehta, L. R. and Schwid, S. R. and Arnold, D. L. and Cutter, G. R. and Aradhye, S. and Balcer, L. J. and Calabresi, P. A. and Cohen, J. A. and Cole, P. E. and Glanzman, R. and Goelz, S. and Inglese, M. and Kapoor, R. and Kappos, L. and Kreitman, R. and Lublin, F. D. and Mann, A. and Marrie, R. A. and O'Looney, P. and Polman, C. H. and Ravina, B. M. and Reingold, S. C. and Richert, J. R. and Sandrock, A. W. and Waubant, E.. (2009) Proof of concept studies for tissue-protective agents in multiple sclerosis. Multiple Sclerosis Journal, 15 (5). pp. 542-546.
Moraal, Bastiaan and Pohl, Christoph and Uitdehaag, Bernard M. J. and Polman, Chris H. and Edan, Gilles and Freedman, Mark S. and Hartung, Hans-Peter and Kappos, Ludwig and Miller, David H. and Montalban, Xavier and Lanius, Vivian and Sandbrink, Rupert and Barkhof, Frederik. (2009) Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study. Archives of neurology, Vol. 66. pp. 1345-1352.
Nielsen, Jessica M. and Pohl, Christoph and Polman, Chris H. and Barkhof, Frederik and Freedman, Mark S. and Edan, Gilles and Miller, David H. and Bauer, Lars and Sandbrink, Rupert and Kappos, Ludwig and Uitdehaag, Bernard M. J.. (2009) MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome. BMC neurology, Vol. 9. p. 19.
O'Connor, P. and Comi, G. and Montalban, X. and Antel, J. and Radue, E. W. and de Vera, A. and Pohlmann, H. and Kappos, L.. (2009) Oral fingolimod (FTY720) in multiple sclerosis : two-year results of a phase II extension study. Neurology : journal of the American Academy of Neurology, Vol. 72. pp. 73-79.
O'Connor, Paul and Filippi, Massimo and Arnason, Barry and Comi, Giancarlo and Cook, Stuart and Goodin, Douglas and Hartung, Hans-Peter and Jeffery, Douglas and Kappos, Ludwig and Boateng, Francis and Filippov, Vitali and Groth, Maria and Knappertz, Volker and Kraus, Christian and Sandbrink, Rupert and Pohl, Christoph and Bogumil, Timon and O'Connor, P. and Filippi, M. and Arnason, B. and Cook, S. and Goodin, D. and Harung, H.-P. and Kappos, L. and Jeffery, D. and Comi, G.. (2009) 250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study. The Lancet neurology, Vol. 8. pp. 889-897.
Palmowski-Wolfe, A. M. and Kappos, L. and Müller-Brand, J. and Buitrago-Tellez, C. and Merlo, A.. (2009) Belastungsabhängige vertikale Doppelbilder und Ptosis. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, Vol. 106. pp. 52-55.
Penner, I. K. and Raselli, C. and Stöcklin, M. and Opwis, K. and Kappos, L. and Calabrese, P.. (2009) The fatigue scale for motor and cognitive functions (FSMC) : validation of a new instrument to assess multiple sclerosis-related fatigue. Multiple Sclerosis Journal, 15 (12). pp. 1509-1517.
Reingold, S. C. and Steiner, J. P. and Polman, C. H. and Cohen, J. A. and Freedman, M. S. and Kappos, L. and Thompson, A. J. and Wolinsky, J. S.. (2009) The challenge of follow-on biologics for treatment of multiple sclerosis. Neurology, Vol. 73, H. 7. pp. 552-559.
Rocca, Maria A. and Absinta, Martina and Valsasina, Paola and Ciccarelli, Olga and Marino, Silvia and Rovira, Alex and Gass, Achim and Wegner, Christiane and Enzinger, Christian and Korteweg, Tjimen and Sormani, Maria Pia and Mancini, Laura and Thompson, Alan J. and De Stefano, Nicola and Montalban, Xavier and Hirsch, Jochen and Kappos, Ludwig and Ropele, Stephan and Palace, Jacqueline and Barkhof, Frederik and Matthews, Paul M. and Filippi, Massimo. (2009) Abnormal connectivity of the sensorimotor network in patients with MS : a multicenter fMRI study. Human brain mapping : a journal devoted to functional neuroanatomy and neuroimaging, Vol. 30. pp. 2412-2425.
Sutter, R. and Killer, H. E. and Bilz, S. and Baumgartner, M. and Ott, H. W. and Steck, A. J. and Renaud, S.. (2009) Cerebral edema and intracranial hypertension in an adult with maple syrup urine disease. European journal of neurology : the official journal of the European Federation of Neurological Societies, Vol. 16, H. 3 , e45-e46.
Vogt, Annamarie and Kappos, Ludwig and Calabrese, Pasquale and Stöcklin, Markus and Gschwind, Leo and Opwis, Klaus and Penner, Iris-Katharina. (2009) Working memory training in patients with multiple sclerosis : a comparison of two different training schedules. Restorative Neurology and Neuroscience, Vol. 27. pp. 225-235.
Bosnell, R. and Wegner, C. and Kincses, Z. T. and Korteweg, T. and Agosta, F. and Ciccarelli, O. and De Stefano, N. and Gass, A. and Hirsch, J. and Johansen-Berg, H. and Kappos, L. and Barkhof, F. and Mancini, L. and Manfredonia, F. and Marino, S. and Miller, D. H. and Montalban, X. and Palace, J. and Rocca, M. and Enzinger, C. and Ropele, S. and Rovira, A. and Smith, S. and Thompson, A. and Thornton, J. and Yousry, T. and Whitcher, B. and Filippi, M. and Matthews, P. M.. (2008) Reproducibility of fMRI in the clinical setting: implications for trial designs. NeuroImage, Vol. 42, H. 2. pp. 603-610.
D'Souza, M. and Kappos, L. and Czaplinski, A.. (2008) Reconsidering clinical outcomes in Multiple Sclerosis : relapses, impairment, disability and beyond. Journal of the neurological sciences, Vol. 274, No. 1-2. pp. 76-79.
Ehrensperger, M. M. and Grether, A. and Romer, G. and Berres, M. and Monsch, A. U. and Kappos, L. and Steck, B.. (2008) Neuropsychological dysfunction, depression, physical disability, and coping processes in families with a parent affected by multiple sclerosis. Multiple Sclerosis Journal, 14 (8). pp. 1106-1112.
Engelhardt, B. and Kappos, L.. (2008) Natalizumab: targeting alpha4-integrins in multiple sclerosis. Neuro-degenerative Diseases, 5 (1). pp. 16-22.
Farrell, R. and Bendtzen, K. and Bertolotto, A. and Clark, B. and Comabella, M. and Deisenhammer, F. and Fogdell-Hahn, A. and Giovannoni, G. and Hartung, H. P. and Hemmer, B. and Hillert, J. and Kappos, L. and Killestein, J. and Lindberg, R. and Montalban, X. and Polman, C. and Sorensen, P. S. and European, Nabinms Consortium. (2008) Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis. Journal of international medical research, Vol. 36, H. 1 , S. 204-208 ; author reply 208-210.
Fox, R. J. and Kappos, L.. (2008) Is natalizumab overshooting its rebound? Neurology, Vol. 70, H. 13, Pt. 2. pp. 1073-1074.
Goodin, D. S. and Cohen, B. A. and O'Connor, P. and Kappos, L. and Stevens, J. C. and Therapeutics, and Technology, Assessment Subcommittee of the American Academy of Neurology. (2008) Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review) : report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology, Vol. 71, H. 10. pp. 766-773.
Gugleta, K. and Mehling, M. and Kochkorov, A. and Grieshaber, M. and Katamay, R. and Flammer, J. and Orgül, S. and Kappos, L.. (2008) Pattern of macular thickness changes measured by ocular coherence tomography in patients with multiple sclerosis. Klinische Monatsblätter für Augenheilkunde, Vol. 225, H. 5. pp. 408-412.
Kappos, L. and Gold, R. and Miller, D. H. and Macmanus, D. G. and Havrdova, E. and Limmroth, V. and Polman, C. H. and Schmierer, K. and Yousry, T. A. and Yang, M. and Eraksoy, M. and Meluzinova, E. and Rektor, I. and Dawson, K. T. and Sandrock, A. W. and O'Neill, G. N.. (2008) Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet, Vol. 372. pp. 1463-1472.
Lindberg, R. L. and Achtnichts, L. and Hoffmann, F. and Kuhle, J. and Kappos, L.. (2008) Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients. Journal of neuroimmunology, Vol. 194. pp. 153-164.
Manson, S. C. and Wegner, C. and Filippi, M. and Barkhof, F. and Beckmann, C. and Ciccarelli, O. and De Stefano, N. and Enzinger, C. and Fazekas, F. and Agosta, F. and Gass, A. and Hirsch, J. and Johansen-Berg, H. and Kappos, L. and Korteweg, T. and Polman, C. and Mancini, L. and Manfredonia, F. and Marino, S. and Miller, D. H. and Montalban, X. and Palace, J. and Rocca, M. and Ropele, S. and Rovira, A. and Smith, S. and Thompson, A. and Thornton, J. and Yousry, T. and Frank, J. A. and Matthews, P. M.. (2008) Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition. Experimental brain research, Vol. 187. pp. 25-31.
Mehling, M. and Brinkmann, V. and Antel, J. and Bar-Or, A. and Goebels, N. and Vedrine, C. and Kristofic, C. and Kuhle, J. and Lindberg, R. L. and Kappos, L.. (2008) FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis. Neurology, Vol. 71, H. 16. pp. 1261-1267.
Miller, D. H. and Weinshenker, B. G. and Filippi, M. and Banwell, B. L. and Cohen, J. A. and Freedman, M. S. and Galetta, S. L. and Hutchinson, M. and Johnson, R. T. and Kappos, L. and Kira, J. and Lublin, F. D. and McFarland, H. F. and Montalban, X. and Panitch, H. and Richert, J. R. and Reingold, S. C. and Polman, C. H.. (2008) Differential diagnosis of suspected multiple sclerosis: a consensus approach. Multiple Sclerosis Journal, 14 (9). pp. 1157-1174.
Oestmann, A. and Achtnichts, L. and Kappos, L. and Gass, A. and Naegelin, Y.. (2008) ["Numb chin syndrome": first presenting syndrome of multiple sclerosis?]. Deutsche medizinische Wochenschrift, Jg. 133, H. 3. pp. 76-78.
Polman, C. and Kappos, L. and Freedman, M. S. and Edan, G. and Hartung, H. P. and Miller, D. H. and Montalbán, X. and Barkhof, F. and Selmaj, K. and Uitdehaag, B. M. and Dahms, S. and Bauer, L. and Pohl, C. and Sandbrink, R. and Benefit, investigators. (2008) Subgroups of the BENEFIT study : risk of developing MS and treatment effect of interferon beta-1b. Journal of neurology, Vol. 255, H. 4. pp. 480-487.
Polman, C. H. and Reingold, S. C. and Barkhof, F. and Calabresi, P. A. and Clanet, M. and Cohen, J. A. and Cutter, G. R. and Freedman, M. S. and Kappos, L. and Lublin, F. D. and McFarland, H. F. and Metz, L. M. and Miller, A. E. and Montalban, X. and O'Connor, P. W. and Panitch, H. and Richert, J. R. and Petkau, J. and Schwid, S. R. and Sormani, M. P. and Thompson, A. J. and Weinshenker, B. G. and Wolinsky, J. S.. (2008) Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Neurology, Vol. 70, H. 13, Pt. 2. pp. 1134-1140.
Sailer, M. and Fazekas, F. and Gass, A. and Kappos, L. and Radue, E. W. and Rieckmann, P. and Toyka, K. and Wiendl, H. and Bendszus, M.. (2008) [Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis]. RÖFO, Vol. 180, H. 11. pp. 994-1001.
Weier, K. and Naegelin, Y. and Thoeni, A. and Hirsch, J. G. and Kappos, L. and Steinbrich, W. and Radue, E. W. and Gass, A.. (2008) Non-communicating syringomyelia : a feature of spinal cord involvement in multiple sclerosis. Brain, Vol. 131, H. 7. pp. 1776-1782.
Sutter, R. and Arber, C. and Tichelli, A. and Steck, A. J. and Czaplinski, A.. (2007) Cranial and peripheral neuropathy due to leptomeningeal infiltration in a patient with Waldenstrom's macroglobulinemia. Journal of neurology, Vol. 254, H. 8. pp. 1122-1123.